Thu. Sep 29th, 2022
Dr Reddy#39;s Labs Q2 profit falls 30% to Rs 762 crore, global generics business up 21% The YoY revenue growth stood at 20 percent after adjusted for proprietary products out-licensing income in the previous year, the company said in its BSE filing.